Jiong Wu

28PUBLICATIONS
68CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPostcolonial studiesPredictive and prognostic markersGenome structure and regulation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Jun 30, 2026
Current practices and trends of axillary surgery de-escalation and lymphedema management for breast cancer in China: a nationwide cross-sectional survey.

|Jun 18, 2026
Spatially interpretable artificial intelligence framework to tailored neoadjuvant dual HER2 blockade in HER2-positive breast cancer.

|Dec 05, 2025
Current Trends in Revision Surgery After Breast Reconstruction in China: Insights from a Nationwide Cross-Sectional Survey.

Yi Zhang, Qi Zhang, Yiding Chen

|Nov 25, 2025
Efficacy and Safety of Neoadjuvant TQB2102 in Locally Advanced or Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: A Randomized, Open-Label, Multicenter, Phase II Trial.

Jun-Jie Li, Wen-Juan Zhang, Xiao-Hua Zeng

|Sep 12, 2025
XBP1s Mediates Cross-resistance to Combination Treatment of CDK4/6 Inhibitors plus Endocrine Therapy in Breast Cancer.

Yuting Sang, Shiyang Liu, Xujie Zhou

|Sep 10, 2025
Interferon-induced senescent CD8+ T cells reduce anti-PD1 immunotherapy efficacy in early triple-negative breast cancer.

Tong Fu, Xi Jin, Min He

Pageof 5

Frequent Collaborators

3 joint publications

Yayun Chi

3 joint publications

Zhi-Ming Shao

3 joint publications

Fei Xavier Chen

2 joint publications

Yonghui Su